Back to Man Group plc Man Group plc

REGNREGN
Showing 8 of 31 quarters

Position history for Man Group plcMan Group plc's holdings in REGENERON PHARMACEUTICALS

Man Group plc holds 436,956 shares of REGN (REGENERON PHARMACEUTICALS), worth $272.5M as of 2026-Q2. The position was increased (+38.6% shares). REGN represents 0.4% of Man Group plc's portfolio.

Current Value

$272.5M

Current Shares

436,956

Total Value Change

+$208.8M

Total Shares Change

+376,435

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
436,956
+38.6%
$272.5M0.4%$622.81
49
2026-Q1
Increased
315,212
+44.5%
$243.5M0.4%$770.59
50
2025-Q4
Decreased
218,112
-19.7%
$168.4M0.3%$768.90
0
2025-Q3
Increased
271,707
+257.6%
$152.8M0.3%$559.40
58
2025-Q2
Increased
75,983
+113.5%
$39.9M0.1%$521.53
47
2025-Q1
Decreased
35,586
-1.5%
$22.6M0.1%$629.11
0
2024-Q4
Decreased
36,144
-40.3%
$25.7M0.1%$705.67
0
2024-Q3
Increased
60,521
+17.0%
$63.6M0.2%$1,041.41
41

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used